Drawing for MOSA-DX

USPTO serial 79415683

MOSA-DX

Reviewed by CopyMark Law Group

Reg. 8190755Status 700Registered
Filing date
Status date
Registration date
Mar 31, 2026
Examiner
CROWLEY, SEAN MICHAEL
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MOSA-DX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alex P Garens

Alex P Garens Day Pitney LLPOne Federal Street, 29th FloorBoston, MA 02110United States

Goods and services

ClassDescriptionStatusFirst use
009Scientific apparatus and instruments for analysing biofluids and detecting diseases; laboratory apparatus and instruments for microscopy, namely, microscopes; scientific apparatus, namely, spectrometers and parts and fittings therefor; spectroscopes; scientific apparatus, namely, spectrophotometers for measuring the infrared spectrum of biofluids for the purpose of detecting diseases; mass spectrometry apparatus; spectrograph apparatus; data processing equipment, namely, couplers; downloadable computer software for use in medical and clinical analysis and disease diagnostics for analyzing medical data to assist in providing clinical interpretations; computer hardware; downloadable electronic publications in the nature of newsletters, reports and brochures in the field of science and medicine; data processing apparatus with artificial intelligence; downloadable artificial intelligence and machine learning software for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; research laboratory analysers for measuring, testing and analysing blood and other bodily fluids.ACTIVE—
010Medical apparatus and instruments for analysing biofluids and detecting diseases; diagnostic apparatus for medical purposes, namely, analysing biofluids and detecting diseases; medical apparatus for the treatment of cancer; blood testing apparatus; medical diagnostic instruments and apparatus for the analysis of bodily fluids; medical apparatus, instruments and devices for liquid biopsy analysis; replacement parts and replacement fittings for all the aforesaid goodsACTIVE—
042Scientific and technological services, namely, research, design, scientific analysis and scientific testing in the field of medical and clinical analysis and disease diagnostics; industrial analysis and research services in the field of medical and clinical analysis and disease diagnostics; design and development of computer hardware and software; design and development of computer software for use with medical technology; engineering services and design services for scientific equipment and apparatus for microscopy, spectroscopy and scientific imaging; medical research services; clinical research in the field of biofluid analysis and disease detection; medical research laboratory services; computer programming in the medical field; design and development of medical technology; design and development of medical diagnostic apparatus; blood analysis services; scientific research for medical purposes in the area of cancerous diseases; research in the field of artificial intelligence; providing on-line non-downloadable software using artificial intelligence for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; software as a service (SaaS) services featuring software using artificial intelligence for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; software as a service (SaaS) services featuring software for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; scientific and technological services, namely, scientific analysis and evaluation of scientific and medical data, in connection with providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; scientific and technological services, namely, computerized scientific analysis of technical data in the field of medical and clinical analysis and disease diagnostics; scientific and technological services, namely, conducting of scientific experiments and tests in the field of medical and clinical analysis and disease diagnostics; scientific, medical, and technological research services, namely, analysis of scientific data and technical data in the field of medical and clinical analysis and disease diagnostics; design of scientific experiments; provision of scientific reports relating to scientific research in the field of medical and clinical analysis and disease diagnostics, namely, scientific research consulting; advice, information and consultancy services for all of the aforesaid services.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 1, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 11, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 10, 2026FIMPFINAL DISPOSITION PROCESSED—
Jul 16, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 30, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 29, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 29, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 31, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 31, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 10, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 10, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 4, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 15, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 22, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 22, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 22, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 7, 2025RFNTREFUSAL PROCESSED BY IB—
May 21, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 21, 2025RFRRREFUSAL PROCESSED BY MPU—
Mar 26, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 25, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 15, 2025DOCKASSIGNED TO EXAMINER—
Feb 14, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 14, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 14, 2025LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jan 30, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance